Schedule II - Valuations and Qualifying Accounts

12 Months Ended

Jun. 30, 2026

SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]

SEC Schedule, 12-09, Schedule of Valuation and Qualifying Accounts Disclosure [Text Block]

Cardinal Health, Inc. and Subsidiaries

Schedule II - Valuation and Qualifying Accounts


(in millions)	Balance at Beginning of Period		Charged to Costs and Expenses (1)		Charged to Other Accounts (2)		Deductions (3)		Balance at End of Period
Fiscal 2026
Accounts receivable	$	213	$	101	$	1	$	(114)	$	201
Finance notes receivable	2		13		—		(8)		7
Sales returns and allowances	447		1,797		—		(1,914)		330

	$	662	$	1,911	$	1	$	(2,036)	$	538

Fiscal 2025
Accounts receivable	$	233	$	88	$	1	$	(109)	$	213
Finance notes receivable	3		3		—		(4)		2
Sales returns and allowances	441		2,155		—		(2,149)		447

	$	677	$	2,246	$	1	$	(2,262)	$	662

Fiscal 2024
Accounts receivable	$	240	$	108	$	—	$	(115)	$	233
Finance notes receivable	6		2		—		(5)		3
Sales returns and allowances	474		2,207		—		(2,240)		441

	$	720	$	2,317	$	—	$	(2,360)	$	677

(1)Fiscal 2026, 2025, and 2024 accounts receivable operating earnings impacts include $40 million, $38 million, and $74 million, respectively, for reserves related to service charges and customer disputes, excluded from provision for bad debts on the consolidated statements of cash flows and classified as a reduction in revenue in the consolidated statements of earnings.

(2)Recoveries of amounts provided for or written off were immaterial for fiscal 2026, 2025, and 2024.

(3)Write-off of uncollectible accounts or actual sales returns.

The sum of the components may not equal the total due to rounding.